Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Methylprednisolone redpharm manufacturer?Amlodipine besylate 10mg?When does the patent for eliquis expire?Methylprednisolone cost without insurance?When does ozempic go generic?
See the DrugPatentWatch profile for farxiga
Farxiga (dapagliflozin) is a prescription diabetes medicine that is commonly placed in a mid- to higher-cost formulary tier, often Tier 3 or Tier 4 on many insurance plans. Exact tier placement depends on the patient’s specific insurance formulary and the plan year.
Drug tiers are set by each insurance plan’s formulary. Farxiga may be placed differently based on: - Whether your plan covers it as preferred brand vs. non-preferred brand - Contracting and rebates with the manufacturer - Step therapy or prior authorization rules (plans may still cover it but at a different cost tier)
Look up Farxiga in your plan’s formulary (pharmacy benefits manager), then check: - The tier number (and name, such as “preferred brand”) - Any prior authorization or step therapy notes - Whether there are lower-cost alternatives (like other SGLT2 inhibitors) in lower tiers If you tell me the insurance name (and state, if you’re in the US) or the plan type (Medicare Part D, employer plan, Medicaid), I can help you figure out where to check and what tier is most likely.
I don’t have your specific insurer’s formulary data in the provided information, so I can’t confirm a single guaranteed tier number for all patients.
Other Questions About Farxiga :